Targeting Akt in cancer for precision therapy

H Hua, H Zhang, J Chen, J Wang, J Liu… - Journal of Hematology & …, 2021 - Springer
Biomarkers-guided precision therapeutics has revolutionized the clinical development and
administration of molecular-targeted anticancer agents. Tailored precision cancer therapy …

The neuroprotective effects of glucagon-like peptide 1 in Alzheimer's and Parkinson's disease: An in-depth review

N Reich, C Hölscher - Frontiers in neuroscience, 2022 - frontiersin.org
Currently, there is no disease-modifying treatment available for Alzheimer's and Parkinson's
disease (AD and PD) and that includes the highly controversial approval of the Aβ-targeting …

Fucoidan structure and activity in relation to anti-cancer mechanisms

G Van Weelden, M Bobiński, K Okła, WJ Van Weelden… - Marine drugs, 2019 - mdpi.com
Fucoidan is a natural derived compound found in different species of brown algae and in
some animals, that has gained attention for its anticancer properties. However, the exact …

Recent advances in understanding the anti-diabetic actions of dietary flavonoids

PVA Babu, D Liu, ER Gilbert - The Journal of nutritional biochemistry, 2013 - Elsevier
Flavonoids are polyphenolic compounds that are abundant in fruits and vegetables, and
increasing evidence demonstrates a positive relationship between consumption of flavonoid …

Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link

Y Zhang, N Huang, F Yan, H Jin, S Zhou, J Shi… - Behavioural brain …, 2018 - Elsevier
It is well known that Alzheimer's disease (AD) is closely related to diabetes mellitus (DM),
and AD is also regarded as Type 3 diabetes (T3D). However, the exact link between AD and …

Mitochondrial function in hypoxic ischemic injury and influence of aging

PB Ham III, R Raju - Progress in neurobiology, 2017 - Elsevier
Mitochondria are a major target in hypoxic/ischemic injury. Mitochondrial impairment
increases with age leading to dysregulation of molecular pathways linked to mitochondria …

[HTML][HTML] Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging

LS Steelman, WH Chappell, SL Abrams… - Aging (Albany …, 2011 - ncbi.nlm.nih.gov
Dysregulated signaling through the Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways
is often the result of genetic alterations in critical components in these pathways or upstream …

Function and regulation of CREB family transcription factors in the nervous system

BE Lonze, DD Ginty - Neuron, 2002 - cell.com
CREB and its close relatives are now widely accepted as prototypical stimulus-inducible
transcription factors. In many cell types, these factors function as effector molecules that …

The protein kinase B/Akt signalling pathway in human malignancy

KM Nicholson, NG Anderson - Cellular signalling, 2002 - Elsevier
Protein kinase B or Akt (PKB/Akt) is a serine/threonine kinase, which in mammals comprises
three highly homologous members known as PKBα (Akt1), PKBβ (Akt2), and PKBγ (Akt3) …

PI3K-Akt pathway: its functions and alterations in human cancer

M Osaki, M Oshimura, H Ito - Apoptosis, 2004 - Springer
Abstract Phosphatidylinositol-3-kinase (PI3K) is a lipid kinase and generates
phosphatidylinositol-3, 4, 5-trisphosphate (PI (3, 4, 5) P3). PI (3, 4, 5) P3 is a second …